KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $99.0 million.

  • CareDx's Total Current Liabilities rose 2161.59% to $99.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.0 million, marking a year-over-year increase of 2161.59%. This contributed to the annual value of $89.4 million for FY2024, which is 1447.25% up from last year.
  • As of Q3 2025, CareDx's Total Current Liabilities stood at $99.0 million, which was up 2161.59% from $93.2 million recorded in Q2 2025.
  • CareDx's Total Current Liabilities' 5-year high stood at $99.0 million during Q3 2025, with a 5-year trough of $45.7 million in Q1 2021.
  • Its 5-year average for Total Current Liabilities is $75.5 million, with a median of $76.0 million in 2022.
  • In the last 5 years, CareDx's Total Current Liabilities soared by 6145.32% in 2021 and then tumbled by 504.74% in 2023.
  • CareDx's Total Current Liabilities (Quarter) stood at $77.3 million in 2021, then fell by 1.72% to $76.0 million in 2022, then increased by 2.76% to $78.1 million in 2023, then rose by 14.47% to $89.4 million in 2024, then increased by 10.82% to $99.0 million in 2025.
  • Its last three reported values are $99.0 million in Q3 2025, $93.2 million for Q2 2025, and $85.3 million during Q1 2025.